Table 1.

EGF genotype and allele frequency in patients with gastric cancer and healthy controls

EGF polymorphismCases (n)Controls* (n)Odds ratio (95% confidence interval)
Genotype
    G/G100 (49.5%)215 (47.8%)1.00 (Reference)
    G/A88 (43.6%)188 (41.8%)1.05 (0.72-1.54)
    A/A14 (6.9%)47 (10.4%)0.58 (0.29-1.17)
    G/A and A/A102 (50.5%)235 (52.2%)0.95 (0.66-1.37)
Allele
    G288 (71.3%)618 (68.7%)1.00 (Reference)
    A116 (28.7%)282 (31.3%)0.87 (0.66-1.16)
  • * Seven of the 454 participants could not be genotyped.

  • Adjusted for age and sex by unconditional logistic regression.